Methods and apparatus for sterilization are presented. An exemplary embodiment includes a sterilizing cabinet assembly. The sterilizing cabinet includes a cabinet having an access port, a door connected to the cabinet, the door moveable between an open position permitting passage through the access port to an interior of the cabinet and a closed position precluding passage through the access port. The sterilizing cabinet assembly also includes at least one of the cabinet and the door having a vent port. The sterilizing cabinet has a primary filter overlying the vent port and forming a sealed interface with an adjacent portion of the one of the cabinet and the door and a secondary filter overlying at least a portion of the primary filter.

The present invention relates to a method for using lectins that bind to pathogens having high mannose surface glycoproteins or fragments thereof which contain high mannose glycoproteins, to remove them from infected blood or plasma in an extracorporeal setting. Accordingly, the present invention provides a method for reducing viral load in an individual comprising the steps of obtaining blood or plasma from the individual, passing the blood or plasma through a porous hollow fiber membrane wherein lectin molecules are immobilized within the porous exterior portion of the membrane, collecting pass-through blood or plasma and reinfusing the pass-through blood or plasma into the individual.

The present invention relates to a method for using lectins that bind to pathogens having high mannose surface glycoproteins or fragments thereof which contain high mannose glycoproteins, to remove them from infected blood or plasma in an extracorporeal setting. Accordingly, the present invention provides a method for reducing viral load in an individual comprising the steps of obtaining blood or plasma from the individual, passing the blood or plasma through a porous hollow fiber membrane wherein lectin molecules are immobilized within the porous exterior portion of the membrane, collecting pass-through blood or plasma and reinfusing the pass-through blood or plasma into the individual.

A sterilization-assistance device is described herein. In some embodiments, the sterilization-assistance device comprises a dry booster and at least one measurement device attached to the dry booster. In various embodiments, the at least one measurement device may include a strain gauge. In various embodiments, the at least one measurement device may include a pressure sensor. In various embodiments, the at least one measurement device may include a pressure sensor and a strain gauge. The sterilization assistance device may also include a communication module. The communication module may be a wireless-communication module. The measurement device may provide indications that the dry booster has become detached from an endoscope during a sterilization procedure.

The present invention provides a method for treating a solution contaminated with porcine circovirus, comprising the steps of: adjusting a pH of a solution contaminated with porcine circovirus to range from 3.0 to 7.0; and treating the pH-adjusted solution with a filtration membrane having an LRV for bacteriophage PP7 of 4 or more.

A method and a device for treating food and/or containers for holding food treats the food and/or containers in at least one treatment zone by a process liquid, wherein the process liquid is at least partially recirculated into the treatment zone or the treatment zones after completed treatment of the food and/or the containers. During continuous treatment at least some or all of the process liquid is used per time unit to form at least one stream of the process liquid, the formed stream is filtered by at least one membrane filtration system, and a filtered stream is at least partially fed back into an element holding and/or conducting the process liquid and/or into a treatment zone.

A method and a device for treating food and/or containers for holding food treats the food and/or containers in at least one treatment zone by a process liquid, wherein the process liquid is at least partially recirculated into the treatment zone or the treatment zones after completed treatment of the food and/or the containers. During continuous treatment at least some or all of the process liquid is used per time unit to form at least one stream of the process liquid, the formed stream is filtered by at least one membrane filtration system, and a filtered stream is at least partially fed back into an element holding and/or conducting the process liquid and/or into a treatment zone.

A method and apparatus of adaptively controlling a surgical stapling instrument are disclose. The method includes identifying a staple cartridge type, configuring the surgical stapling instrument based on the identified staple cartridge, and adaptively controlling, by a control circuit, operation/functionality of the surgical stapling instrument based on the configuration of the surgical stapling instrument loaded with the identified staple cartridge type. The apparatus includes a control circuit including a microcontroller and a memory coupled to the microcontroller. The memory stores machine executable instructions that when executed by the microcontroller cause the microcontroller to execute the above method.

Apparatus, system, and methods are provided for reducing infectious agents at a sterile site by preventing infectious agents from coming into contact with the sterile site. A barrier is produced for infectious agents that may come in proximity or otherwise communicate with the site. The apparatus is configured to create a void-free barrier in which infectious agents are reduced with minimal exposure of potentially harmful effects of the barrier to the sterile site, objects, or users of the apparatus.

Apparatus, system, and methods are provided for reducing infectious agents at a sterile site by preventing infectious agents from coming into contact with the sterile site. A barrier is produced for infectious agents that may come in proximity or otherwise communicate with the site. The apparatus is configured to create a void-free barrier in which infectious agents are reduced with minimal exposure of potentially harmful effects of the barrier to the sterile site, objects, or users of the apparatus.